**
A recent analysis has revealed a troubling increase in the number of cancer patients opting for ivermectin over traditional chemotherapy, a trend attributed largely to celebrity endorsements and misinformation spread through popular media platforms. The findings, published by the JAMA Network, highlight the potential dangers of alternative treatments in the face of life-threatening illnesses.
Rising Prescriptions of Ivermectin
Between January and July 2025, prescriptions for ivermectin among cancer patients surged, with reports indicating a 2.5-fold increase compared to the same period in 2024. The study identified that white males from the southern United States were the demographic most likely to seek this unproven treatment. Ivermectin, primarily known as an anti-parasitic medication, gained notoriety during the COVID-19 pandemic, primarily among those sceptical of vaccines. However, its use for cancer treatment lacks any credible scientific backing.
The study’s authors, including Drs. Michelle S. Rockwell, Katherine L. Kahn, and A. Mark Fendrick, expressed serious concerns over the implications of these findings: “Patients with cancer may delay or forgo effective treatments in favour of unverified therapies, potentially allowing their conditions to worsen,” they stated. This troubling trend underscores the influence of misinformation, particularly when amplified by high-profile figures.
Celebrity Influence and Misinformation
The rise in ivermectin prescriptions can be traced back to a specific celebrity endorsement. In January 2025, actor Mel Gibson appeared on the Joe Rogan Experience podcast, sharing anecdotal accounts of friends who purportedly overcame cancer using ivermectin and benzimidazole—a compound commonly found in agricultural products. The episode garnered over 60 million views across various platforms, significantly amplifying the message.
Dr. Richard Simcock, Chief Medical Officer at MacMillan Cancer Support, remarked on the concerning volume of social media discussions promoting ivermectin for cancer treatment. He stated, “There is currently zero real-world clinical evidence that it might be helpful in the treatment of cancer.” The misleading narratives surrounding ivermectin often stem from laboratory studies that suggest it could induce cancer cell death when used alongside conventional therapies. However, these findings cannot be directly applied to human patients, and ivermectin has never been proven effective on its own.
The Dangers of Alternative Treatments
Despite the lack of scientific validation, many cancer patients are increasingly turning to ivermectin, driven by both desperation and the allure of quick solutions. In addition to the absence of proven efficacy, the use of ivermectin can lead to adverse side effects, including increased nausea and discomfort, complicating the already challenging experience of cancer treatment.
Regulatory bodies, such as the Food and Drug Administration (FDA), have not approved ivermectin for any use beyond treating parasitic infections, yet the drug’s status as an alternative treatment continues to gain traction among certain groups. This trend raises important questions about the responsibility of media platforms and celebrities in guiding public health narratives.
Why it Matters
The implications of this trend are profound. As cancer patients increasingly turn to unproven therapies, the potential for negative health outcomes escalates. This situation serves as a stark reminder of the power of misinformation and the urgent need for public health officials and medical professionals to counteract misleading narratives. Ensuring that patients have access to accurate information is crucial, especially when their lives are on the line. The responsibility lies not only with healthcare providers but also with those who wield influence in the public sphere, highlighting the critical intersection of health communication and patient safety in today’s media landscape.
